An evaluation of half-body irradiation in the treatment of widespread, painful metastatic bone disease

Tumori

Volumn 94, Issue 6, 2008, Pages 813-821

  Miszczyk, Leszek ^a   Tukiendorf, Andrzej ^b   Gaborek, Aleksandra ^c   Wydmański, Jerzy ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Cardiff Research Consortium   (United Kingdom)

^c Good Compassion Hospice   (Poland)

Author keywords

Bone metastases; Halfbody irradiation; Quality of life

Indexed keywords

CODEINE; FENTANYL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RATING SCALE;

EID: 61349185102     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400607     Document Type: Article

References (40)

1. Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, Fogelman I, Houston S, Fauser A, Fischer M, Wilkins D: A dose-controlled study of 153 Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer, 33:1583-1591, 1997.
2. Seraflni AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Coller BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA: Palliation for pain associated with metastatic bone cancer using Samarium 153 lexidronam: a double blind placebo-controlled clinical trial. J Clin Oncol, 16: 1574-1581, 1998.
3. Silberstein EB, Eugene L, Saenger SR: Painful osteoblastic metastases: the role of nuclear medicine. Oncology, 15: 157-163, 2001.
4. Bos SD: An overview of current clinical experiences with strontium-89 (Metastron). Prostate, (Suppl 5): 23-26, 1994.
5. Bremer M, Rades D, Blach M, Krenkel M, Karstens JH: Effectiveness of hypofractionated radiotherapy in painful bone metastases. Two prospective studies with 1x4 Gy and 4x4 Gy. Strahlenther Onkol, 175: 382-386, 1999.
6. Ben-Josef E, Shamsa F, Williams AO, Porter AT: Radiotherapeutic management of osseus metastases: a survey of current patterns or care. Int J Radiat Oncol Biol Phys, 40: 915-921, 1998.
7. Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finklestein J, Andersson L, Connolly R: Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol, 56: 305-314, 2000.
8. Dearnaley DP, Bayly RJ, A'Hern RP, Gadd J, Zivanovic MM, Levington VJ: Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89. Clin Oncol, 4: 101-107, 1992.
9. Korb L: Radiotherapy for the palliation of prostate cancer. Semin Surg Oncol, 18: 75-79, 2000.
10. Miszczyk L, Gaborek A, Wydmański J: The evaluation of life quality after HBI performed due to multiple skeletal dissemination. Ortop Traumat Rehab, 5: 215-218, 2003.
11. Miszczyk L, Gaborek A, Wydmański J: An effectiveness evaluation of hemibody irradiation as a palliative treatment of patients with multiple, painful bone dissemination. Wspolcz Onkol, 9: 218-222, 2005.
12. Miszczyk L, Sasiadek: W Evaluation of hemibody irradiation effectiveness as palliation of patients with multiple bone metastases. Przegl Lek, 58: 431-434, 2001.
13. Nag S, Shah V: Once-a-week lower hemibody irradiation (HBI) for metastatic cancers. Int J Radiat Oncol Biol Phys, 12: 1003-1005, 1986.
14. Nseyo UO, Fontanesi J, Naftulin BN: Palliative hemibody irradiation in hormonally refractory metastatic prostate cancer. Urology, 34: 76-79, 1989.
15. Poulter CA, Cosmatos D, Rubin P, Urtasun R, Cooper JS, Kuske RR, Hornback N, Couglin C, Weigensberg I, Rotman M: A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys, 23: 207-214, 1992.
16. Salazar O, Da Motta NW, Bridgman SM, Cardiges NM, Slawson RG: Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys, 36: 49-60, 1996.
17. Salazar O, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, Asbell SO, Mohiuddin M, Van Ess J: Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Cancer, 58: 29-36, 1986.
18. Salazar O, Sandhu T, Da Motta NW, Ferez Escutia MA, Lanzos-Gonzales E, Mouelle-Sone A, Moscol A, Zaharia M, Zaman S: Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized phase III trial of the International Atomic Energy Agency (IAEA) Int J Radiat Oncol Biol Phys, 50: 765-775, 2001.
19. Salazar O, Scarantino CW: Theorethical and practical uses of elective systemic (half-body) irradiation after 20 years of experimental designs. Int J Radiat Oncol Biol Phys, 39: 907-913, 1997.
20. Skolyszewski J, Sas-Korczyńska B, Korzeniowski S, Reinfuss M: The efficiency and tolerance of half-body irradiation (HBI) in patients with multiple metastases. Strahlenther Oncol, 177: 482-486, 2001.
21. Duchesne GM, Harmer CL: Hemibody irradiation in lymphomas and related malignancies Int J Radiat Oncol Biol Phys, 11: 2003-2006, 1985.
22. Scarantino CW, Greven KM, Buss DH: Single high dose large field irradiation in drug resistant non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys, 14: 1001-1005, 1988.
23. Plesnicar A, Jereb B, Zalatel-Kragelj L: Half-body irradiation in the treatment of multiple myeloma: a report of nine cases. Tumori, 82: 588-591, 1996.
24. Quasim MM: Techniques and results of half body irradiation (HBI) in metastatic carcinomas and myelomas. Clin Oncol, 5: 65-68, 1979.
25. Luksch R, Podda M, Gandola L, Polastri D, Piva L, Castellani R, Collini P, Massimino M, Cefalo G, Terenciani M, Ferrari A, Casanova M, Spreafico F, Meazza C, Bozzi F, Marchiano A, Ravagnani F, Fossati-Bellani F: Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoetic stem cell transplantation to consolidate primary treatment. Br J Cancer, 92: 1984-1988, 2005.
26. Tomiska M, Tomiskova M, Saljka F, Adam Z, Vorlicek J: Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. Neoplasma, 50: 227-233, 2003.
27. Cleeland CS, Ryan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore, 23: 129-138, 1994.
28. Miszczyk L, Ficek K, Trela K, Spindel J: The efficacy of radiotherapy for vertebral hemangiomas. Neoplasma, 48: 82-84, 2001.
29. Janda M, Gerstner M, Obermair A, Fuerst A, Wachter S, Dieckmann K, Potter R: Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer, 89: 1322-1328, 2000.
30. Wojtowicz JG, Wierzbicka M, Szyfter W: Usefulness of questionnaire EORTC QLQ-C30 and EORTC QLQ-H&N35 in assessment of quality of life before surgical treatment in patients with head and neck cancer. Otolaryngol Pol, 55: 627-634, 2001.
31. Kessler PA, Bloch-Birkholz A, Leher A, Neukam FW, Wiltfang J: Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Radiother Oncol, 70: 275-282, 2004.
32. Wierzbicka M, Kusnierkiewicz M, Wojtowicz JG, Maune S, Szyfter W: The quality of life in head and neck cancer patients - description of randomised examination formula based on standarised questionnaires EORTC QLQ-C30, EORTC QLQ-H&N35 and Kiel Questionnaire. Otolaryngol Pol, 55: 287-292, 2001.
33. Gralla RJ: Quality of life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life. Oncologists, 9: 14-24, 2004.
34. Hagelin CL, Seiger A, Furst CJ: Quality of life in terminal care -with special reference to age, gender and marital status. Support Care Cancer, 14: 320-228, 2006.
35. Horns MYV, Essink-Bot ML, Borsboom GJJM, Steyerberg EW, Siersema PD: Quality of life after palliative treatment for oesophageal carcinoma: a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer, 40: 1862-1871, 2004.
36. Park SM, Park MH, Won JH, Lee KO, Choe WS, Heo DS, Kim SY, Lee KS, Yun YH: EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units. Support Care Cancer 14: 329-333, 2006.
37. Esbansen BA, Osterlind K, Roer O, Hallberg IR: Quality of life of elderly persons with newly diagnosed cancer. Eur J Cancer Care, 13: 443-453, 2004.
38. Thome B, Hallberg IR: Quality of life in older people with cancer - a gender perspective. Eur J Cancer Care, 13: 454-463, 2004.
39. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleihsman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneuw KCA, Sullivan M, Takeda R: The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85: 365-376, 1993.
40. rd edition), European Organisation for Research and Treatment of Cancer, Brussels, 2001.